|
FRMD8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.431000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.785000E-01 |
| Normal-vs-Stage2 |
7.078000E-01 |
| Normal-vs-Stage3 |
6.264000E-02 |
| Normal-vs-Stage4 |
6.798600E-01 |
| Stage1-vs-Stage2 |
5.797000E-01 |
| Stage1-vs-Stage3 |
1.966290E-02 |
| Stage1-vs-Stage4 |
7.872000E-01 |
| Stage2-vs-Stage3 |
1.235960E-01 |
| Stage2-vs-Stage4 |
5.343600E-01 |
| Stage3-vs-Stage4 |
1.517980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.264600E-01 |
| Normal-vs-AfricanAmerican |
6.425600E-01 |
| Normal-vs-Asian |
9.526600E-01 |
| Caucasian-vs-AfricanAmerican |
7.017600E-01 |
| Caucasian-vs-Asian |
9.759000E-01 |
| AfricanAmerican-vs-Asian |
8.595000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.273400E-01 |
| Normal-vs-Female |
3.277000E-01 |
| Male-vs-Female |
3.582400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.340400E-01 |
| Normal-vs-Extreme_Weight |
7.482000E-01 |
| Normal-vs-Obese |
5.945400E-01 |
| Normal-vs-Extreme_Obese |
5.618600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.204800E-01 |
| Normal_Weight-vs-Obese |
5.357800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.883200E-01 |
| Extreme_Weight-vs-Obese |
7.962600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.593400E-01 |
| Obese-vs-Extreme_Obese |
4.063400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.068500E-02 |
| Normal-vs-Age(41-60Yrs) |
8.540200E-02 |
| Normal-vs-Age(61-80Yrs) |
4.564800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.726020E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.047600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.321780E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.993000E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.064500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.616500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.932000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.760000E-01 |
| Normal-VS-Type2 PRCC |
5.186200E-01 |
| Normal-VS-KIRP CIMP |
2.124700E-03 |
| Normal-VS-Unclassified PRCC |
6.832600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.306000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.060700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.273400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.199900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.584400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.049970E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.333200E-01 |
| Normal-vs-N1 |
1.229430E-01 |
| Normal-vs-N2 |
7.006000E-01 |
| N0-vs-N1 |
7.988100E-02 |
| N0-vs-N2 |
5.976600E-01 |
| N1-vs-N2 |
6.577000E-01 |
|
|
